Komori
Takeda Machinery (6150) · FactRestated

No Research and Development Expenses in the Quarter

First written in FY2017-Q1. 28 of 30 entries say "Restated". Latest entry: FY2026-H1.

30entries
11years
0from disclosures
Share on X
How it moved
ProgressHeldSoftenedWorseRestatedFY2017-Q1 – FY2026-H12016: 12017: 420172018: 420182019: 420192020: 420202021: 220212022: 220222023: 320232024: 320242025: 220252026: 1
Same theme, other companies
No Research and Development Activities ConductedA theme 34 companies write about · 19 as a headwind · 0 as a tailwind

22 other companies' latest entry also says "Restated".

Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Showing 14 of the 34 companies compared. The sentences above are computed from all 34.
Full recordFilings, disclosures and news, newest first
  1. FY2026-H1RestatedAnnual report

    「There were no R&D expenses during the interim consolidated accounting period under review.」

    The Company disclosed that it also had no R&D expenses during the interim consolidated accounting period under review.
  2. FY2025RestatedAnnual report

    「6. R&D Activities There are no applicable matters.」

    The Company disclosed that there were no applicable matters concerning R&D activities during the consolidated fiscal year under review.
  3. FY2025-H1RestatedAnnual report

    「There were no R&D expenses during the interim consolidated accounting period under review.」

    The Company disclosed that there were no R&D expenses during the interim consolidated accounting period.
  4. FY2024Start of recording R&D expensesAnnual report

    「Total R&D expenses for the consolidated fiscal year under review amounted to ¥3 million. As the Group operates in a single segment, the metalworking machinery business, segment information has been omitted. During the consolidated fiscal year under review, the Group's R&D activities involved analyzing the cutting of steel materials using circular saws.」

    After previously disclosing that it had no R&D expenses, the Company recorded ¥3 million in the current fiscal year and conducted analysis of steel cutting using circular saws.
  5. FY2024-Q3RestatedAnnual report

    「There were no R&D expenses during the cumulative third quarter of the consolidated fiscal year under review.」

    The Company disclosed that it also had no R&D expenses during the cumulative third quarter.
  6. FY2024-Q2RestatedAnnual report

    「There were no R&D expenses during the cumulative second quarter of the consolidated fiscal year under review.」

    The Company disclosed that it also had no R&D expenses during the cumulative second quarter.
  7. FY2024-Q1RestatedAnnual report

    「There were no research and development expenses during the first quarter of the current consolidated cumulative period.」

    The Company disclosed that it also had no R&D expenses during the cumulative first quarter of the consolidated fiscal year under review.
  8. FY2023-Q3RestatedAnnual report

    「There were no R&D expenses during the cumulative third quarter of the consolidated fiscal year under review.」

    The Company disclosed that it also had no R&D expenses during the cumulative third quarter.
  9. FY2023-Q2RestatedAnnual report

    「There were no R&D expenses during the cumulative second quarter of the consolidated fiscal year under review.」

    The Company disclosed that it also had no R&D expenses during the cumulative FY2023-Q2 period.
  10. FY2023-Q1RestatedAnnual report

    「There were no research and development expenses during the first quarter of the current consolidated cumulative period.」

    The Company disclosed that it also had no R&D expenses during the cumulative first quarter of the consolidated fiscal year under review.
  11. FY2022-Q2RestatedAnnual report

    「There were no R&D expenses during the cumulative second quarter of the consolidated fiscal year under review.」

    The Company disclosed that it also had no R&D expenses during the cumulative second quarter.
  12. FY2021RestatedAnnual report

    「Not applicable.」

    The Company disclosed that there were no applicable matters concerning R&D activities during the consolidated fiscal year under review.
  13. FY2021-Q2RestatedAnnual report

    「There were no R&D expenses during the cumulative second quarter of the consolidated fiscal year under review.」

    The Company disclosed that it also had no R&D expenses during the cumulative second quarter.
  14. FY2021-Q1RestatedAnnual report

    「There were no research and development expenses during the first quarter of the current consolidated cumulative period.」

    The Company disclosed that it also had no R&D expenses during the cumulative first quarter of the consolidated fiscal year under review.
  15. FY2020RestatedAnnual report

    「Not applicable.」

    The Company disclosed that there were no applicable matters concerning R&D activities during the consolidated fiscal year under review.
  16. FY2020-Q3RestatedAnnual report

    「There were no R&D expenses during the cumulative third quarter of the consolidated fiscal year under review.」

    The Company disclosed that it also had no R&D expenses during the cumulative third quarter.
  17. FY2020-Q2RestatedAnnual report

    「There were no R&D expenses during the cumulative second quarter of the consolidated fiscal year under review.」

    The Company disclosed that it also had no R&D expenses during the cumulative second quarter.
  18. FY2020-Q1RestatedAnnual report

    「There were no research and development expenses during the first quarter of the current consolidated cumulative period.」

    The Company disclosed that it also had no R&D expenses during the cumulative first quarter of the consolidated fiscal year under review.
  19. FY2019RestatedAnnual report

    「Not applicable.」

    The Company disclosed that there were no applicable matters concerning R&D activities during the consolidated fiscal year under review.
  20. FY2019-Q3RestatedAnnual report

    「There were no R&D expenses during the cumulative third quarter of the consolidated fiscal year under review.」

    The Company disclosed that it also had no R&D expenses during the cumulative third quarter.
  21. FY2019-Q2RestatedAnnual report

    「There were no R&D expenses during the cumulative second quarter of the consolidated fiscal year under review.」

    The Company disclosed that it also had no R&D expenses during the cumulative second quarter.
  22. FY2019-Q1RestatedAnnual report

    「There were no research and development expenses during the first quarter of the current consolidated cumulative period.」

    The Company disclosed that it also had no R&D expenses during the cumulative first quarter of the consolidated fiscal year under review.
  23. FY2018RestatedAnnual report

    「Not applicable.」

    The Company disclosed that there were no applicable matters concerning R&D activities during the consolidated fiscal year under review.
  24. FY2018-Q3RestatedAnnual report

    「There were no R&D expenses during the cumulative third quarter of the consolidated fiscal year under review.」

    The Company disclosed that it also had no R&D expenses during the cumulative third quarter.
  25. FY2018-Q2RestatedAnnual report

    「There were no R&D expenses during the cumulative second quarter of the consolidated fiscal year under review.」

    The Company disclosed that it also had no R&D expenses during the cumulative second quarter.
  26. FY2018-Q1RestatedAnnual report

    「There were no research and development expenses during the first quarter of the current consolidated cumulative period.」

    The Company disclosed that it also had no R&D expenses during the cumulative first quarter of the consolidated fiscal year under review.
  27. FY2017RestatedAnnual report

    「Not applicable.」

    The Company disclosed that there were no applicable matters concerning R&D activities during the consolidated fiscal year under review.
  28. FY2017-Q3RestatedAnnual report

    「There were no R&D expenses during the cumulative third quarter of the consolidated fiscal year under review.」

    The Company disclosed that it also had no R&D expenses during the cumulative third quarter.
  29. FY2017-Q2RestatedAnnual report

    「There were no R&D expenses during the cumulative second quarter of the consolidated fiscal year under review.」

    The Company disclosed that, following the first quarter, it also had no R&D expenses during the cumulative second quarter.
  30. FY2017-Q1First statedAnnual report

    「There were no research and development expenses during the first quarter of the current consolidated cumulative period.」

    Discloses that there were no research and development expenses during the first quarter of the current consolidated cumulative period.
Moved together

None of this company's other threads moved the same way in the same document twice or more.

When this could move next
No upcoming earnings preview for Takeda Machinery yet.
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.